We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
3 Medical Services Industry Stocks to Buy as Healthcare Wage Increases
Read MoreHide Full Article
The three-year-long historic public health crisis significantly altered the structure and trend of the Medical Services sector. The growing demand for remote treatment led to a tremendous upsurge in digital healthcare options. Demand for digital healthcare treatment continues to grow in the form of telemedicine-focused online medical and AI-powered technology services backed by the adoption of data and analytics.
According to a recent Mordor Intelligence report, the global healthcare analytics market is expected to surpass $130 billion by 2029, witnessing a CAGR of 22.9% from 2024 to 2029. Primary stakeholders — payers, healthcare professionals and patients — will benefit from all-new insights, services and levels of experience that next-generation healthcare-related data and analytical capabilities provide. Stocks like ICON plc (ICLR - Free Report) , Organon & Co. (OGN - Free Report) and Doximity (DOCS - Free Report) are expected to gain the most from the rapidly transforming healthcare services landscape.
However, in the post-pandemic era, manual workforce shortage within healthcare has become a worldwide problem, weighing heavily on healthcare infrastructure. In April 2023, the National Council of State Boards of Nursing revealed that within United States, 100,000 nurses left the workforce during the pandemic, and by 2027, almost 900,000, or almost one-fifth of 4.5 million total registered nurses, intend to leave the workforce, threatening the national health care system at large if solutions are not enacted.
Industry Description
The Zacks Medical Services industry comprises third-party service providers and caregivers appointed by core healthcare companies for economies of scale. The industry includes pharmacy benefit managers, contract research organizations, wireless MedTech companies, third-party testing labs, surgical facility providers, and healthcare workforce solution providers, among others. Over the years, this industry has strategically moved from volume- to value-based care. This changing pattern of care calls for advanced facilities, thus increasing the need to appoint specialized external service providers. With the growing importance of effective healthcare management, the medical service industry has become an integral part of the modern healthcare system.
3 Trends Shaping the Future of the Medical Services Industry
Digital Revolution: With an increase in the adoption of digital platforms within the medical device space, remote monitoring, robotic surgeries, big-data analytics, 3D printing and electronic health records are gaining prominence in the United States. A 2024 digital health market report by Statista suggests that this market will witness a 9.2% CAGR from 2024 to 2028, resulting in a projected market volume of $275 billion by 2028. Other reports suggest that companies that adopted artificial intelligence technologies witnessed a 50% reduction in treatment costs and experienced more than 50% improvement in patient outcomes.
Revival in Nursing Care Market: With rising cognizance about the benefits of specialized medical caregiving, the need for healthcare workforce/staffing service providers has increased significantly. Despite challenges like workforce shortages and increased costs, the market is rebounding post-pandemic. Factors such as rising chronic diseases, healthcare awareness and strategic initiatives by companies and governments drive this growth. For example, the demand for nurses has increased manifold, driven by the rising incidence of chronic disorders in the United States, and is expected to be high in the days ahead. Per a Research and Markets report, the global healthcare staffing market size is expected to reach $62.8 billion by 2030, registering a CAGR of 6.9% from 2023 to 2030.
Staffing Shortage: Despite the end of the healthcare emergency (WHO declared the end of COVID-19 as a global health emergency on May 5), the trauma of the past few years’ uncertainty and commotion has forced frontline workers like doctors and medical staff to leave the field. Added to this, a drastic increase in the aging population in recent times (about 10,000 individuals aged 59-77 are joining Medicare plans daily) has made the healthcare staffing shortage more pronounced. In the article "A Public Health Crisis: Staffing Shortages in Health Care," published in Favorite Healthcare Staffing, WHO predicts a shortfall of 15 million healthcare workers worldwide in 2030. Needless to say, this supply shortage has led to a significant rise in healthcare wages. Going by a HR for Health report, increased labor costs and staffing challenges have led to a rise in hospital expenses. Hospitals have experienced a 15.6% increase in labor expenses per adjusted discharge compared to pre-pandemic levels.
Zacks Industry Rank Indicates Improving Prospects
The Zacks Medical Services industry falls within the broader Zacks Medical sector. It carries a Zacks Industry Rank #91, which places it in the top 36% of more than 250 Zacks industries.
The group’s Zacks Industry Rank, which is basically the average of the Zacks Rank of all the member stocks, indicates improving near-term prospects. Our research shows that the top 50% of the Zacks-ranked industries outperforms the bottom 50% by a factor of more than 2 to 1.
We will present a few stocks that have the potential to outperform the market based on a strong earnings outlook. But it’s worth taking a look at the industry’s shareholder returns and current valuation first.
Industry Underperforms Sector and S&P 500
The Medical Services Industry has underperformed its sector and the S&P 500 over the past year. The stocks in this industry have collectively gained 3.1% during the said time frame compared with the Medical sector’s 6.2% rise and the S&P 500 composite’s surge of 20.1%.
One-Year Price Performance
Industry's Current Valuation
On the basis of forward 12-month price-to-earnings (P/E), which is commonly used for valuing medical stocks, the industry is currently trading at 15.26X compared with the S&P 500’s 21.17X and the sector’s 23.61X.
Over the last five years, the industry has traded as high as 19.91X, as low as 11.83X, and at the median of 14.59X, as the charts below show.
Price-to-Earnings Forward Twelve Months (F12M)
Price-to-Earnings Forward Twelve Months (F12M)
3 Stocks to Buy Right Now
Below, we present three stocks from the Medical Services industry that have been witnessing positive earnings estimate revisions and carry a Zacks Rank #1 (Strong Buy) or #2 (Buy) at present.
Doximity: It is a digital platform for U.S. medical professionals. The company's network members include over 80% of U.S. physicians across all specialties and practice areas. Doximity provides its verified clinical membership with digital tools built for medicine, enabling them to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and on-call schedules and conduct virtual patient visits.
This Zacks Rank #1 stock’s fiscal 2025 expected earnings growth rate is pegged at 4.2%. The Zacks Consensus Estimate for DOCS’ fiscal 2025 revenues indicates a year-over-year rise of 7.7%.
Price and Consensus: DOCS
Organon: It develops and delivers health solutions through a portfolio of prescription therapies and medical devices within women's health in the United States and internationally. As per its recent plans, Organon is currently significantly expanding the production of long-acting contraception in the Netherlands. Of late, the company has entered into various collaborations and acquisitions worldwide to expand its portfolio of medicines and other health solutions.
Organon’s 2024 earnings growth rate is pegged at 7.9%. The Zacks Consensus Estimate for OGN’s 2024 revenues indicates a year-over-year rise of 1.7%. The stock sports a Zacks Rank #1 currently.
Price and Consensus: OGN
ICON: Based in Ireland, ICON is a clinical research organization. ICON is gaining from its focused patient, site and data strategy, which is helping it to improve site identification, study placement and patient recruitment and retention. In this regard, Accellacare, ICON's global clinical research network, is successfully offering customers a wide range of stand-alone and integrated solutions at the site or in patients' homes as part of decentralized trials.
ICON’s 2024 expected earnings growth rate is pegged at 17.9%. The Zacks Consensus Estimate for ICLR’s 2024 revenues indicates a year-over-year rise of 6.1%. The stock carries a Zacks Rank #2 at present.
Price and Consensus: ICLR
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
3 Medical Services Industry Stocks to Buy as Healthcare Wage Increases
The three-year-long historic public health crisis significantly altered the structure and trend of the Medical Services sector. The growing demand for remote treatment led to a tremendous upsurge in digital healthcare options. Demand for digital healthcare treatment continues to grow in the form of telemedicine-focused online medical and AI-powered technology services backed by the adoption of data and analytics.
According to a recent Mordor Intelligence report, the global healthcare analytics market is expected to surpass $130 billion by 2029, witnessing a CAGR of 22.9% from 2024 to 2029. Primary stakeholders — payers, healthcare professionals and patients — will benefit from all-new insights, services and levels of experience that next-generation healthcare-related data and analytical capabilities provide. Stocks like ICON plc (ICLR - Free Report) , Organon & Co. (OGN - Free Report) and Doximity (DOCS - Free Report) are expected to gain the most from the rapidly transforming healthcare services landscape.
However, in the post-pandemic era, manual workforce shortage within healthcare has become a worldwide problem, weighing heavily on healthcare infrastructure. In April 2023, the National Council of State Boards of Nursing revealed that within United States, 100,000 nurses left the workforce during the pandemic, and by 2027, almost 900,000, or almost one-fifth of 4.5 million total registered nurses, intend to leave the workforce, threatening the national health care system at large if solutions are not enacted.
Industry Description
The Zacks Medical Services industry comprises third-party service providers and caregivers appointed by core healthcare companies for economies of scale. The industry includes pharmacy benefit managers, contract research organizations, wireless MedTech companies, third-party testing labs, surgical facility providers, and healthcare workforce solution providers, among others. Over the years, this industry has strategically moved from volume- to value-based care. This changing pattern of care calls for advanced facilities, thus increasing the need to appoint specialized external service providers. With the growing importance of effective healthcare management, the medical service industry has become an integral part of the modern healthcare system.
3 Trends Shaping the Future of the Medical Services Industry
Digital Revolution: With an increase in the adoption of digital platforms within the medical device space, remote monitoring, robotic surgeries, big-data analytics, 3D printing and electronic health records are gaining prominence in the United States. A 2024 digital health market report by Statista suggests that this market will witness a 9.2% CAGR from 2024 to 2028, resulting in a projected market volume of $275 billion by 2028. Other reports suggest that companies that adopted artificial intelligence technologies witnessed a 50% reduction in treatment costs and experienced more than 50% improvement in patient outcomes.
Revival in Nursing Care Market: With rising cognizance about the benefits of specialized medical caregiving, the need for healthcare workforce/staffing service providers has increased significantly. Despite challenges like workforce shortages and increased costs, the market is rebounding post-pandemic. Factors such as rising chronic diseases, healthcare awareness and strategic initiatives by companies and governments drive this growth. For example, the demand for nurses has increased manifold, driven by the rising incidence of chronic disorders in the United States, and is expected to be high in the days ahead. Per a Research and Markets report, the global healthcare staffing market size is expected to reach $62.8 billion by 2030, registering a CAGR of 6.9% from 2023 to 2030.
Staffing Shortage: Despite the end of the healthcare emergency (WHO declared the end of COVID-19 as a global health emergency on May 5), the trauma of the past few years’ uncertainty and commotion has forced frontline workers like doctors and medical staff to leave the field. Added to this, a drastic increase in the aging population in recent times (about 10,000 individuals aged 59-77 are joining Medicare plans daily) has made the healthcare staffing shortage more pronounced. In the article "A Public Health Crisis: Staffing Shortages in Health Care," published in Favorite Healthcare Staffing, WHO predicts a shortfall of 15 million healthcare workers worldwide in 2030. Needless to say, this supply shortage has led to a significant rise in healthcare wages. Going by a HR for Health report, increased labor costs and staffing challenges have led to a rise in hospital expenses. Hospitals have experienced a 15.6% increase in labor expenses per adjusted discharge compared to pre-pandemic levels.
Zacks Industry Rank Indicates Improving Prospects
The Zacks Medical Services industry falls within the broader Zacks Medical sector. It carries a Zacks Industry Rank #91, which places it in the top 36% of more than 250 Zacks industries.
The group’s Zacks Industry Rank, which is basically the average of the Zacks Rank of all the member stocks, indicates improving near-term prospects. Our research shows that the top 50% of the Zacks-ranked industries outperforms the bottom 50% by a factor of more than 2 to 1.
We will present a few stocks that have the potential to outperform the market based on a strong earnings outlook. But it’s worth taking a look at the industry’s shareholder returns and current valuation first.
Industry Underperforms Sector and S&P 500
The Medical Services Industry has underperformed its sector and the S&P 500 over the past year. The stocks in this industry have collectively gained 3.1% during the said time frame compared with the Medical sector’s 6.2% rise and the S&P 500 composite’s surge of 20.1%.
One-Year Price Performance
Industry's Current Valuation
On the basis of forward 12-month price-to-earnings (P/E), which is commonly used for valuing medical stocks, the industry is currently trading at 15.26X compared with the S&P 500’s 21.17X and the sector’s 23.61X.
Over the last five years, the industry has traded as high as 19.91X, as low as 11.83X, and at the median of 14.59X, as the charts below show.
Price-to-Earnings Forward Twelve Months (F12M)
Price-to-Earnings Forward Twelve Months (F12M)
3 Stocks to Buy Right Now
Below, we present three stocks from the Medical Services industry that have been witnessing positive earnings estimate revisions and carry a Zacks Rank #1 (Strong Buy) or #2 (Buy) at present.
You can see the complete list of today’s Zacks #1 Rank stocks here.
Doximity: It is a digital platform for U.S. medical professionals. The company's network members include over 80% of U.S. physicians across all specialties and practice areas. Doximity provides its verified clinical membership with digital tools built for medicine, enabling them to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and on-call schedules and conduct virtual patient visits.
This Zacks Rank #1 stock’s fiscal 2025 expected earnings growth rate is pegged at 4.2%. The Zacks Consensus Estimate for DOCS’ fiscal 2025 revenues indicates a year-over-year rise of 7.7%.
Price and Consensus: DOCS
Organon: It develops and delivers health solutions through a portfolio of prescription therapies and medical devices within women's health in the United States and internationally. As per its recent plans, Organon is currently significantly expanding the production of long-acting contraception in the Netherlands. Of late, the company has entered into various collaborations and acquisitions worldwide to expand its portfolio of medicines and other health solutions.
Organon’s 2024 earnings growth rate is pegged at 7.9%. The Zacks Consensus Estimate for OGN’s 2024 revenues indicates a year-over-year rise of 1.7%. The stock sports a Zacks Rank #1 currently.
Price and Consensus: OGN
ICON: Based in Ireland, ICON is a clinical research organization. ICON is gaining from its focused patient, site and data strategy, which is helping it to improve site identification, study placement and patient recruitment and retention. In this regard, Accellacare, ICON's global clinical research network, is successfully offering customers a wide range of stand-alone and integrated solutions at the site or in patients' homes as part of decentralized trials.
ICON’s 2024 expected earnings growth rate is pegged at 17.9%. The Zacks Consensus Estimate for ICLR’s 2024 revenues indicates a year-over-year rise of 6.1%. The stock carries a Zacks Rank #2 at present.
Price and Consensus: ICLR